PERKINS CAPITAL MANAGEMENT INC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 294 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
PERKINS CAPITAL MANAGEMENT INC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$252
+8.6%
5,550
-1.8%
0.25%
+23.8%
Q2 2023$232
+14.9%
5,6500.0%0.20%
+6.3%
Q1 2023$202
-16.5%
5,650
-11.7%
0.19%
-25.5%
Q4 2022$242
-99.9%
6,4000.0%0.26%
-19.6%
Q3 2022$283,000
+1.1%
6,400
+85.5%
0.32%
+72.3%
Q1 2019$280,000
+34.6%
3,450
-10.4%
0.18%
+14.3%
Q4 2018$208,000
-12.6%
3,850
-28.7%
0.16%
-24.8%
Q1 2018$238,000
-30.4%
5,400
-20.6%
0.21%
-35.0%
Q4 2017$342,000
-18.2%
6,800
-17.6%
0.33%
-24.9%
Q3 2017$418,000
+3.5%
8,250
+3.8%
0.44%
-2.2%
Q2 2017$404,000
+16.1%
7,950
-8.1%
0.45%
+24.8%
Q1 2017$348,000
-16.9%
8,650
-1.1%
0.36%
-21.8%
Q4 2016$419,000
-15.0%
8,750
-34.9%
0.46%
-6.9%
Q3 2016$493,000
+39.7%
13,450
-11.2%
0.49%
+21.7%
Q2 2016$353,000
-43.2%
15,150
-1.3%
0.40%
-48.0%
Q1 2016$622,000
-49.5%
15,350
-22.9%
0.78%
-41.1%
Q4 2015$1,232,00019,9001.32%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders